Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
Richard L. Wahl, George Sgouros, Amir Iravani, Heather A. Jacene, Daniel A. Pryma, Babak Saboury, Jacek Capala, Stephen A. Graves
Abstract
Radiopharmaceutical therapies are gaining increasing prominence as they improve survival in patients with common diseases such as metastatic prostate cancer ([ 1 ][1],[ 2 ][2]). However, whereas sodium iodide (131I) therapy has been used for over 70 y in treating malignant and benign thyroid
Topics & Concepts
MedicineThyroid cancerThyroidProstate cancerSodium iodideRadioiodine therapyCancerNuclear medicineInternal medicineChemistryOrganic chemistryRadiopharmaceutical Chemistry and ApplicationsMedical Imaging Techniques and ApplicationsProstate Cancer Treatment and Research